Biomarkers of treatment-resistant schizophrenia: A systematic review.

A miR-137-Related Biological Pathway of Risk for Schizophrenia Is Associated With Human Brain Emotion Processing.

Polygenic scores of subcortical brain volumes as possible modulators of treatment response in depression.

An integrated precision medicine approach in major depressive disorder: a study protocol to create a new algorithm for the prediction of treatment response.

DNA methylation changes in association with trauma-focused psychotherapy efficacy in treatment-resistant depression patients: a prospective longitudinal study.

Genome-wide association studies of response and side effects to the BNT162b2 vaccine in Italian healthcare workers: Increased antibody levels and side effects in carriers of the HLA-A*03:01 allele.

The role of pharmacogenetics in the treatment of major depressive disorder: a critical review.

Biological markers of sex-based differences in major depressive disorder and in antidepressant response.

LRRK2 Kinase Inhibition Attenuates Neuroinflammation and Cytotoxicity in Animal Models of Alzheimer's and Parkinson's Disease-Related Neuroinflammation.

Not So Fast On Virtual Interviewing.

Dopamine-Dependent Ketamine Modulation of Glutamatergic Synaptic Plasticity in the Prelimbic Cortex of Adult Rats Exposed to Acute Stress.

Investigation on the high recurrence of the ATTRv-causing transthyretin variant Val142Ile in central Italy.

Author Correction: Assessment of haptoglobin alleles in autism spectrum disorders.

Multi-omics data integration methods and their applications in psychiatric disorders.

Transcriptional Profiling of Rat Prefrontal Cortex after Acute Inescapable Footshock Stress.